Latin America and the Caribbean: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Latin America and the Caribbean

The Latin American prophylactic medicaments containing insulin market dropped modestly to $X in 2022, falling by -2.3% against the previous year. The market value increased at an average annual rate of +3.0% over the period from 2012 to 2022; however, the trend pattern remained relatively stable, with somewhat noticeable fluctuations being observed in certain years. The level of consumption peaked at $X in 2019; however, from 2020 to 2022, consumption failed to regain momentum.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Latin America and the Caribbean

In value terms, prophylactic medicaments containing insulin production reduced slightly to $X in 2022 estimated in export price. The total output value increased at an average annual rate of +2.7% from 2012 to 2022; however, the trend pattern remained relatively stable, with only minor fluctuations being observed throughout the analyzed period. The most prominent rate of growth was recorded in 2013 when the production volume increased by 12%. Over the period under review, production reached the maximum level at $X in 2019; however, from 2020 to 2022, production failed to regain momentum.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports in Latin America and the Caribbean

In 2022, exports of medicaments containing insulin but not antibiotics in measured doses in Latin America and the Caribbean soared to X tons, jumping by 24% compared with the year before. Over the period under review, exports, however, recorded a drastic downturn. The growth pace was the most rapid in 2013 when exports increased by 40%. The volume of export peaked at X tons in 2014; however, from 2015 to 2022, the exports stood at a somewhat lower figure.

In value terms, prophylactic medicaments containing insulin exports skyrocketed to $X in 2022. In general, exports, however, faced a abrupt decrease. The level of export peaked at $X in 2013; however, from 2014 to 2022, the exports stood at a somewhat lower figure.

Exports by Country

Brazil prevails in exports structure, recording X tons, which was approx. 94% of total exports in 2022. It was distantly followed by Panama (X tons), generating a 4.6% share of total exports.

Exports from Brazil decreased at an average annual rate of -8.4% from 2012 to 2022. Panama (-2.3%) illustrated a downward trend over the same period. While the share of Panama (+2.2 p.p.) increased significantly, the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Brazil ($X) remains the largest prophylactic medicaments containing insulin supplier in Latin America and the Caribbean, comprising 89% of total exports. The second position in the ranking was taken by Panama ($X), with a 6.8% share of total exports.

From 2012 to 2022, the average annual rate of growth in terms of value in Brazil stood at -15.8%.

Export Prices by Country

In 2022, the export price in Latin America and the Caribbean amounted to $X per ton, rising by 32% against the previous year. Overall, the export price, however, recorded a abrupt descent. The level of export peaked at $X per ton in 2012; however, from 2013 to 2022, the export prices remained at a lower figure.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Panama ($X per ton), while Brazil amounted to $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Panama (-4.4%).

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports in Latin America and the Caribbean

In 2022, approx. X tons of medicaments containing insulin but not antibiotics in measured doses were imported in Latin America and the Caribbean; declining by -15.4% against 2021 figures. Total imports indicated measured growth from 2012 to 2022: its volume increased at an average annual rate of +4.1% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2014 when imports increased by 29% against the previous year. Over the period under review, imports attained the maximum at X tons in 2021, and then fell rapidly in the following year.

In value terms, prophylactic medicaments containing insulin imports declined to $X in 2022. In general, imports saw a mild setback. The growth pace was the most rapid in 2014 when imports increased by 25%. As a result, imports reached the peak of $X. From 2015 to 2022, the growth of imports remained at a somewhat lower figure.

Imports by Country

In 2022, Colombia (X tons), distantly followed by Brazil (X tons), Argentina (X tons) and Chile (X tons) represented the largest importers of medicaments containing insulin but not antibiotics in measured doses, together achieving 73% of total imports. The following importers - El Salvador (X tons), Guatemala (X tons), Honduras (X tons), Ecuador (X tons), Costa Rica (X tons), Nicaragua (X tons), Paraguay (X tons) and Peru (X tons) - together made up 21% of total imports.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main importing countries, was attained by Ecuador (with a CAGR of +29.2%), while imports for the other leaders experienced more modest paces of growth.

In value terms, Colombia ($X), Chile ($X) and Brazil ($X) were the countries with the highest levels of imports in 2022, with a combined 52% share of total imports. Argentina, Paraguay, Ecuador, Peru, Honduras, Costa Rica, Guatemala, El Salvador and Nicaragua lagged somewhat behind, together comprising a further 37%.

Costa Rica, with a CAGR of +25.3%, saw the highest rates of growth with regard to the value of imports, in terms of the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The import price in Latin America and the Caribbean stood at $X per ton in 2022, with an increase of 5.3% against the previous year. Over the period under review, the import price, however, continues to indicate a abrupt setback. Over the period under review, import prices attained the maximum at $X per ton in 2012; however, from 2013 to 2022, import prices failed to regain momentum.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was Peru ($X per ton), while Brazil ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Paraguay (+1.4%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :